Schedule 13G ownership disclosure
Halozyme Therapeutics Inc
Security class unavailable · CUSIP: 40637H109
Event date: 2014-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-15-010094
- Form type
- SC 13G
- Filer
- BAKER BROS. ADVISORS LP
- CIK
- CIK 1263508
- Filed
- Feb 17, 2015
- Reporting period
- Dec 31, 2014
- Description
- Schedule 13G beneficial ownership